Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$94.35 USD

94.35
239,975

+0.59 (0.63%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $94.34 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (186 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Orthofix (OFIX) Advances in ALIF Procedure With New Launch

Orthofix (OFIX) WaveForm A interbody features a wave-like design, providing a balance of strength, porosity and stability, along with a large implant graft aperture for bone graft material.

Quest Diagnostics (DGX) Partners to Offer New Testing Service

Quest Diagnostics' (DGX) latest test indicates how different genes and their variants affect how a person reacts to drugs.

Here's Why You Should Buy Boston Scientific (BSX) Stock

Investors are optimistic about Boston Scientific's (BSX) strong improvement in organic sales, indicating a solid rebound in the legacy business.

What's in Store for Patterson Companies (PDCO) in Q4 Earnings?

Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect an improvement at the Animal Health segment.

3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio

Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge.

IDEXX (IDXX) Stock Up 18.4% YTD: Will the Rally Continue?

The continued solid demand for veterinary services and benefits from strong execution poise IDEXX (IDXX) well for future growth.

Hologic (HOLX) Gains From Core Businesses' Growth, Innovation

Hologic's (HOLX) GYN Surgical business grows organically as the company registers procedural volumes return and acceleration from new business lines.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

Surmodics' (SRDX) Receipt of New FDA Nod to Boost Patient Care

Surmodics' (SRDX) receipt of FDA's clearance is expected to expand the treatment range of the Pounce platform and serve a wider patient pool.

Cardinal Health (CAH) to Build Distribution Center in Greenville

Cardinal Health's (CAH) new facility will be its largest at-Home Solutions distribution center that will support business growth by providing new space and automation.

CONMED (CNMD) Stock Hits 52-Week High: Will It Continue?

CONMED (CNMD) continues to raise optimism in investors due to its broad product spectrum.

IDEXX (IDXX) Launches First Veterinary Diagnostic Test

IDEXX's (IDXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes.

3 Reasons to Hold Patterson Companies (PDCO) Stock for Now

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

BD's (BDX) Latest Product to Automate Clinical Flow Cytometry

The latest worldwide commercial availability of BD's (BDX) product is expected to lead to increased automation in clinical lab workflow.

Neogen (NEOG) Introduces Improved Genomic Test for Cats

Neogen's (NEOG) My CatScan 2.0 offers insightful genetic information that enables preventive cat care by tackling curable conditions.

Here's Why You Should Invest in Hologic (HOLX) Stock Now

Investors are optimistic about Hologic (HOLX) on continued strength in GYN Surgical and Breast Health businesses.

Masimo (MASI) Inks Deals for Patient Monitoring Technologies

Masimo's (MASI) advanced monitoring technologies and solutions attract new customers looking for better patient care, using remote and centralized surveillance, and seamless data transfer to EMRs.

NextGen (NXGN) Expands Partnership With Large Urology Group

NextGen's (NXGN) cloud-based healthcare technology solution, Enterprise EHR, is selected by Associated Urologists of North Carolina to create an integrated platform, especially for urology-specific workflows.

Reasons to Add West Pharmaceutical (WST) to Your Portfolio Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Encompass Health's (EHC) 158th Hospital Opens in Maryland

The Rehabilitation Hospital of Bowie is Encompass Health's (EHC) second location in the state of Maryland.

QIAGEN's (QGEN) QCI Is Used by Danish National Genome Center

QIAGEN's (QGEN) QCI Interpret offers evidence-based variant interpretation and reporting, and upholds the highest standards for data security and privacy. It also provides testing sites flexibility.

Here's Why You Should Retain Illumina (ILMN) Stock for Now

Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.

CVS Heath (CVS) MinuteClinic Earns 6th Health Care Approval

CVS Heath's (CVS) MinuteClinic has an in-clinic Net Promotor Score of more than 81, putting it in the top customer rankings.

Revvity (RVTY) Launches Single Solution for Drug Development

Revvity (RVTY) Signals Software suite integrates streamlining data, global monitoring and customizable workflows and covers the entire Make-Test-Decide lifecycle, which can be centrally managed.

Merit Medical (MMSI) Expands Suite via Buyouts, Revises FY23 View

Merit Medical's (MMSI) latest addition to its portfolio is expected to significantly enhance patient outcomes.